Financials
- Market Capitalization 292.22 M
- Employee 55
- Founded 2015
- CEO N/A
- Website www.fulcrumtx.com
- Headquarter Delaware, United States
- FIGI BBG00DDY1RK9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3320 | TTRX Turn Therapeutics Inc. - Common Stock | 9.85 USD | -2.57% | +3.47% | +28.76% | -1.50% | 293.41 M USD | ||
| 3327 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.64 USD | -3.31% | -4.84% | +25.52% | +5.24% | 291.66 M USD | ||
| 3371 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.13 USD | -3.42% | +3.67% | +6.60% | -34.19% | 285.79 M USD | ||
| 3390 | PYXS Pyxis Oncology, Inc. - Common Stock | 3.24 USD | -2.41% | +5.19% | +11.72% | +141.79% | 270.24 M USD |
Frequently asked questions about Fulcrum Therapeutics, Inc. Common Stock
What is the Fulcrum Therapeutics, Inc. Common Stock stock price today?
The current price of Fulcrum Therapeutics, Inc. Common Stock (FULC) is 3.83. Over the past 24 hours, the stock has changed by -0.52%. Follow the FULC chart for real-time price dynamics.
What is the stock ticker of Fulcrum Therapeutics, Inc. Common Stock?
Fulcrum Therapeutics, Inc. Common Stock trades under the ticker FULC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Fulcrum Therapeutics, Inc. Common Stock stock going up?
FULC has changed by 0.00% over the last week, +3.79% over the last month, and -42.92% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Fulcrum Therapeutics, Inc. Common Stock?
Fulcrum Therapeutics, Inc. Common Stock currently has a market capitalization of 292.22 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Fulcrum Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Fulcrum Therapeutics, Inc. Common Stock reported earnings of -0.34 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Fulcrum Therapeutics, Inc. Common Stock net income for the last quarter?
Fulcrum Therapeutics, Inc. Common Stock reported net income of -26.18 M for the last quarter. The previous quarter showed -18.89 M, which means net income changed by -38.58%.
How many employees does Fulcrum Therapeutics, Inc. Common Stock have?
As of the latest available data, Fulcrum Therapeutics, Inc. Common Stock has 55 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Fulcrum Therapeutics, Inc. Common Stock stock?
You can buy Fulcrum Therapeutics, Inc. Common Stock (FULC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Fulcrum Therapeutics, Inc. Common Stock stock?
Investing in Fulcrum Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FULC chart and related analysis on metatrader.com as part of your research.